0001193805-22-000420.txt : 20220303
0001193805-22-000420.hdr.sgml : 20220303
20220303211435
ACCESSION NUMBER: 0001193805-22-000420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rossi Michael A.
CENTRAL INDEX KEY: 0001783869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 22711831
MAIL ADDRESS:
STREET 1: C/O HARVARD BIOSCIENCE, INC.
STREET 2: 84 OCTOBER HILL ROAD #10
CITY: HOLLISTON
STATE: MA
ZIP: 01746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
4
1
e621404_4-michael.xml
X0306
4
2022-03-01
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001783869
Rossi Michael A.
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON
MA
01746
0
1
0
0
Chief Financial Officer
Common Stock
2022-03-01
4
A
0
31021
0.00
A
255117
D
Common Stock
2022-03-01
4
A
0
28716
0.00
A
283833
D
Represents an award of 31,021 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person.
Includes (a) the award described in footnote (1) above, (b) 43,092 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 36,876 restricted stock units with performance based vesting conditions, (e) 23,878 remaining restricted stock units that will vest on July 18, 2022, (f) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (g) 73,064 shares of common stock beneficially owned by the Reporting Person.
Represents an award of 28,716 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2022 to the earlier of (i) December 31, 2024, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.
/s/ Michael A. Rossi
2022-03-03